Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13).

Tripodi, A; Peyvandi, F; Chantarangkul, V; Palla, R; Afrasiabi, A; Canciani, M T; Chung, D W; Ferrari, S; Fujimura, Y; Karimi, M; Kokame, K; Kremer Hovinga, J A; Lämmle, B; de Meyer, S F; Plaimauer, B; Vanhoorelbeke, K; Varadi, K; Mannucci, P M

Tripodi, A; Peyvandi, F; Chantarangkul, V; Palla, R; Afrasiabi, A; Canciani, M T; Chung, D W; Ferrari, S; Fujimura, Y; Karimi, M; Kokame, K; Kremer Hovinga, J A; Lämmle, B; de Meyer, S F; Plaimauer, B; Vanhoorelbeke, K; Varadi, K; Mannucci, P M.

Affiliation

Tripodi A; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Internal Medicine and Medical Specialties, University and IRCCS Maggiore Hospital, Milan, Italy. armando.tripodi@unimi.it

J Thromb Haemost ; 6(9): 1534-41, 2008 Sep.

Article in En | MEDLINE | ID: mdl-18662260

Subject(s)

ADAM Proteins/blood; Cooperative Behavior; von Willebrand Factor/metabolism; ADAMTS13 Protein; Humans; Hydrolysis; Reference Standards; Reproducibility of Results

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Von Willebrand Factor / Cooperative Behavior / ADAM Proteins Type of study: Clinical_trials Limits: Humans Language: En Journal: J Thromb Haemost Year: 2008 Document type: Article

Fulltext

XML

PubMed Links

Search on Google